Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Charite - Universitaetsmedizin Berlin |
| Country | Germany |
| Start Date | Feb 01, 2023 |
| End Date | Jan 31, 2028 |
| Duration | 1,825 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 101078713 |
Cellular interactions are of fundamental importance in life, orchestrating organismal development, tissue homeostasis and immunity.
In the immune system, cell-cell interactions act as central hubs for information processing and decision making that collectively determine the outcome of complex immune responses.
In leukemias, a cancer originating from immature immune cells, a multilayered network of cellular interactions between immune and leukemic cells underlies effective immune control of the cancer, immune evasion and response to immunotherapies.
However, technical limitations in studying cell-cell interactions restrict our understanding into these highly complex and dynamic processes.
In order to overcome this limitation, I propose to develop a novel interact-omics approach, capable of characterizing millions of cellular interactions across complex organ systems, entire organisms and patient cohorts.
Applying the interact-omics approach to sophisticated leukemia mouse models will enable us to dissect the dynamic cellular interaction networks between antigen-specific T cells, bystander immune cells and leukemic cells that drive anti-leukemia immunity and immune evasion.
In combination with the in vivo perturbation of cellular interactions, this will allow us to systematically decode the cellular logic of how the complex leukemia-immune interplay determines the disease course.
Additionally, by making use of leukemia patient cohorts which are either responsive or non-responsive to immunotherapy treatment, we will unravel previously unknown therapy resistance mechanisms and predict therapy response.
Together, our approach will set the basis for a comprehensive understanding of the leukemia-immune cell crosstalk underlying immune control, immune escape and therapy response, and may serve as a blueprint to fundamentally expand our insights into other biological processes driven by cellular interactions.
Charite - Universitaetsmedizin Berlin
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant